We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT02724696
Previous Study | Return to List | Next Study

French National Observatory of Patients With Thymic Epithelial Tumor (RYTHMIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02724696
Recruitment Status : Recruiting
First Posted : March 31, 2016
Last Update Posted : June 30, 2022
Sponsor:
Information provided by (Responsible Party):
Intergroupe Francophone de Cancerologie Thoracique

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a French nationwide network for TET with the objective of territorial coverage by regional expert centers and systematic discussion of patients management at national tumor board.

Condition or disease
Thymic Epithelial Tumor

Detailed Description:

RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a nationwide network for TET appointed in 2012 by the French National Cancer Institute. The objectives of the network are management of clinical tumor boards and central pathologic review of all cases. RYTHMIC Tumor Board is based on initial histopathological diagnosis.

RYTHMIC is a comprehensive tool for research:

  • to improve the management of patients
  • to monitor dedicated actions
  • to screen patients for future translational and clinical trials
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 3262 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: French National Observatory of Patients With Thymic Epithelial Tumor
Actual Study Start Date : January 2012
Estimated Primary Completion Date : December 2025
Estimated Study Completion Date : December 2025

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. histological type [ Time Frame: 5 years ]
    histological type according to the WHO classification 2004/2015

  2. Masaoka-Koga stage [ Time Frame: 5 years ]
    Masaoka-Koga stage

  3. ITMIG/IASLC 2014/2015 stage [ Time Frame: 5 years ]
    ITMIG/IASLC 2014/2015 stage


Secondary Outcome Measures :
  1. Questions raised at the national expert multidisciplinary tumor board [ Time Frame: 5 years ]
    Diagnosis/Imaging, Surgery, Chemotherapy, Radiotherapy


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with Thymic Epithelial Tumors
Criteria

Inclusion Criteria:

  • patient with Thymic Epithelial Tumors

Exclusion Criteria:

  • histology other than Thymic Epithelial Tumors
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02724696


Contacts
Layout table for location contacts
Contact: Franck Morin contact@ifct.fr

Locations
Layout table for location information
France
Paris - Institut Curie Recruiting
Paris, France, 75005
Contact: Nicolas GIRARD, Pr       contact@ifct.fr   
Villejuif - Institut Gustave Roussy Recruiting
Villejuif, France, 94800
Contact: Benjamin BESSE, Dr       contact@ifct.fr   
Sponsors and Collaborators
Intergroupe Francophone de Cancerologie Thoracique
Investigators
Layout table for investigator information
Principal Investigator: Benjamin BESSE, Dr Villejuif - Gustave Roussy
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Layout table for additonal information
Responsible Party: Intergroupe Francophone de Cancerologie Thoracique
ClinicalTrials.gov Identifier: NCT02724696    
Other Study ID Numbers: IFCT-1104 RYTHMIC
First Posted: March 31, 2016    Key Record Dates
Last Update Posted: June 30, 2022
Last Verified: June 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Intergroupe Francophone de Cancerologie Thoracique:
Thymic Epithelial Tumor
Cohort study
IFCT
Additional relevant MeSH terms:
Layout table for MeSH terms
Neoplasms, Glandular and Epithelial
Thymus Neoplasms
Neoplasms
Neoplasms by Histologic Type
 Thoracic Neoplasms
Neoplasms by Site
Lymphatic Diseases